Diabetes(suger)

â??PHARMACO-THERAPEUTIC ROLE OF BIJKADI YOG (KALPIT YOG) IN MANAGEMENT OF MADHUMEHA W.S.R. TO DIABETES MELLITUS.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/01/017241

Enrollment

Registered

2019-01-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: group A bijakadi yog: 500mg bd tab with palash puspahim for one month Control Intervention1: group B - madhumehari churna: madhumehri churna 3gm bd with water for one month

Eligibility

Inclusion criteria

Inclusion criteria: (a) Diagnosed and confirmed cases of Diabetes Mellitus type II, on the basis of the laboratory investigations. (b) Patients between the age group of 18-60 years of either sex.

Exclusion criteria

Exclusion criteria: 1. Patients having Type - DM I [IDDM] 2. Age below 18 and above 60 years. 3. Patient of type II DM who are on Insulin therapy. 4. DM with complications. 5. Uncontrolled DM 8. Drug induced DM. 9. FBS [ >250mg/dl] 10. PPBS [ >300mg/dl] 11. DM with coronary artery disease

Design outcomes

Primary

Measure	Time frame
To evaluate pharmacological and therapeutic efficacy of drug bijkadi yogTimepoint: 8 months	—

Secondary

Measure	Time frame
To evaluate the effect of bijkadi yog on control sugar level in diabetes mellitesTimepoint: one month	—

Countries

India

Contacts

Public Contactbalraj singh rathore

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur

drlnsharma5178@gmail.com9413095390

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026